BOOTHBAY FUND MANAGEMENT, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$109,000
-86.0%
96,883
-62.8%
0.00%
-83.3%
Q1 2022$778,000
+489.4%
260,146
+423.1%
0.02%
+500.0%
Q4 2021$132,000
-45.2%
49,735
-25.2%
0.00%
-57.1%
Q3 2021$241,000
-18.9%
66,522
-2.8%
0.01%
-30.0%
Q2 2021$297,000
+139.5%
68,456
+88.5%
0.01%
+100.0%
Q1 2021$124,000
-58.4%
36,319
-57.3%
0.01%
-54.5%
Q4 2020$298,000
-40.5%
85,049
-59.3%
0.01%
-63.3%
Q3 2020$501,000
+17.6%
208,821
-10.3%
0.03%
+3.4%
Q2 2020$426,000
+25.7%
232,850
+7.3%
0.03%
+3.6%
Q1 2020$339,000
+149.3%
217,050
+241.2%
0.03%
+133.3%
Q4 2019$136,000
+142.9%
63,609
+319.5%
0.01%0.0%
Q3 2016$56,000
-18.8%
15,163
-50.8%
0.01%
-55.6%
Q2 2016$69,000
+4.5%
30,830
-2.5%
0.03%
+8.0%
Q1 2016$66,000
-10.8%
31,610
+28.7%
0.02%
-24.2%
Q4 2015$74,000
+76.2%
24,568
+43.9%
0.03%
+65.0%
Q3 2015$42,000
+2.4%
17,068
+50.2%
0.02%
-25.9%
Q1 2015$41,00011,3600.03%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders